Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Elisa Garbayo"'
Autor:
Natalia López-González Del Rey, Ana Quiroga-Varela, Elisa Garbayo, Iria Carballo-Carbajal, Rubén Fernández-Santiago, Mariana H. G. Monje, Inés Trigo-Damas, María J. Blanco-Prieto, Javier Blesa
Publikováno v:
Frontiers in Neuroanatomy, Vol 12 (2018)
When James Parkinson described the classical symptoms of the disease he could hardly foresee the evolution of our understanding over the next two hundred years. Nowadays, Parkinson’s disease is considered a complex multifactorial disease in which g
Externí odkaz:
https://doaj.org/article/ba5a5c7e1f9c45ceb9517adbc40fe0c6
Autor:
Laura Saludas, Cláudia C. Oliveira, Carmen Roncal, Adrián Ruiz-Villalba, Felipe Prósper, Elisa Garbayo, María J. Blanco-Prieto
Publikováno v:
Nanomaterials, Vol 11, Iss 3, p 570 (2021)
Extracellular vesicles (EVs) are constituted by a group of heterogeneous membrane vesicles secreted by most cell types that play a crucial role in cell–cell communication. In recent years, EVs have been postulated as a relevant novel therapeutic op
Externí odkaz:
https://doaj.org/article/0d20a95a28ce4432a592033ba8bbbd25
Autor:
Rubén Del Campo-Montoya, María-Rosario Luquin, Elena Puerta, Elisa Garbayo, María J. Blanco-Prieto
Publikováno v:
Expert Opinion on Drug Delivery. 19:1521-1537
Parkinson's disease is the second most common neurodegenerative disease. Currently, there are no curative therapies, with only symptomatic treatment available. One of the principal reasons for the lack of treatments is the problem of delivering drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43accac1372e86781194fd577dda123f
https://doi.org/10.1080/17425247.2022.2136161
https://doi.org/10.1080/17425247.2022.2136161
Autor:
Pablo Vicente Torres-Ortega, Rubén Del Campo-Montoya, Daniel Plano, Jacobo Paredes, Javier Aldazabal, María-Rosario Luquin, Enrique Santamaría, Carmen Sanmartín, María J. Blanco-Prieto, Elisa Garbayo
Publikováno v:
Biomacromolecules. 23:4629-4644
The co-administration of glial cell line-derived neurotrophic factor (GDNF) and mesenchymal stem cells (MSCs) in hydrogels (HGs) has emerged as a powerful strategy to enhance the efficient integration of transplanted cells in Parkinson's disease (PD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e03fd4240792c351df91201dd992ddc8
https://doi.org/10.1021/acs.biomac.2c00853
https://doi.org/10.1021/acs.biomac.2c00853
Autor:
Paula Gil-Cabrerizo, Laura Saludas, Felipe Prósper, Gloria Abizanda, Miguel Echanove-González de Anleo, Adrián Ruiz-Villalba, Elisa Garbayo, María J. Blanco-Prieto
Extracellular vesicles (EVs) are nanosized pArtículos with attractive therapeutic potential for cardiac repair. However, low retention and stability after systemic administration limit their clinical translation. As an alternative, the combination o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::460958041c6663e6b91945067b560692
https://hdl.handle.net/10668/22271
https://hdl.handle.net/10668/22271
Publikováno v:
European Journal of Pharmaceutical Sciences. 185:106439
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c0a51935197220cd25645cd978cc1e5
https://doi.org/10.1016/j.ejps.2023.106439
https://doi.org/10.1016/j.ejps.2023.106439
Autor:
Laura Saludas, Elisa Garbayo, Adrián Ruiz-Villalba, Silvia Hernández, Pieter Vader, Felipe Prósper, María J. Blanco-Prieto
Publikováno v:
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
instname
Since the discovery of the beneficial therapeutical effects of extracellular vesicles (EVs), these agents have been attracting great interest as next-generation therapies. EVs are nanosized membrane bodies secreted by all types of cells that mediate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8314208ff0b0653babced29a81ebb4c4
https://hdl.handle.net/10171/63709
https://hdl.handle.net/10171/63709
Autor:
Pablo Vicente Torres-Ortega, Laura Saludas, Jon Eneko Idoyaga, Carlos Rodríguez-Nogales, Elisa Garbayo, María José Blanco-Prieto
Publikováno v:
Nanoparticles for Brain Drug Delivery ISBN: 9781003119326
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0415ad42e796997a94fa4464d7d20f3f
https://doi.org/10.1201/9781003119326-8
https://doi.org/10.1201/9781003119326-8
Autor:
Carmen Roncal, María J. Blanco-Prieto, Laura Saludas, Beatriz Pelacho, Adrián Ruiz-Villalba, Elisa Garbayo, Silvia C. Hernandez, B. Sanchez, Igor F. Palacios, Gloria Abizanda, Felipe Prosper
Publikováno v:
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
instname
Despite tremendous progress in cell-based therapies for heart repair, many challenges still exist. To enhance the therapeutic potential of cell therapy one approach is the combination of cells with biomaterial delivery vehicles. Here, we developed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::043efba8310072a746042f7ba4b3330c
https://hdl.handle.net/10171/63703
https://hdl.handle.net/10171/63703
Publikováno v:
Proceedings of The 1st International Electronic Conference on Pharmaceutics.
Introduction: Glial cell line-derived neurotrophic factor (GDNF) is a well-establish therapeutic agent for Parkinson’s disease (PD) 1. Its therapeutic potential, being a glycosylated protein, will largely depend on the possibility of administering
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1be36c060e7cae5b5bc89cdf1729acd
https://doi.org/10.3390/iecp2020-08799
https://doi.org/10.3390/iecp2020-08799